Kazantzis, Dimitrios http://orcid.org/0000-0002-4145-8144
Holmes, Christopher
Wijesingha, Naomi http://orcid.org/0000-0003-0206-1061
Sivaprasad, Sobha
Article History
Received: 2 November 2023
Revised: 22 February 2024
Accepted: 2 April 2024
First Online: 8 April 2024
Competing interests
: SS reported receiving financial support from AbbVie, Amgen, Apellis, Bayer, Biogen, Boehringer Ingelheim, Novartis, Eyebiotech, Eyepoint Pharmaceuticals, Janssen Pharmaceuticals, Nova Nordisk, Optos, Ocular Therapeutics, Kriya Therapeutics, OcuTerra, Roche, Stealth Biotherapeutics, Sanofi and is a member of the Eye Editorial Board. All other authors declare no conflict of interest.